Cordyceps Sunshine Biotech Holdings (RAJAF) Assets Average (2021 - 2025)

Cordyceps Sunshine Biotech Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $4.6 million for Q4 2025.

• In Q4 2025, Assets Average rose 16.37% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (up 16.37% YoY), while the FY2025 annual figure was $4.6 million, up 16.37% from the prior year.
• Assets Average was $4.6 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $4.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.6 million in Q4 2025 to a low of $2.0 million in Q3 2023.
• Historically, Assets Average has averaged $3.1 million across 5 years, with a median of $2.9 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Assets Average fell 11.84% in 2022, then surged 54.88% in 2024.
• A 5-year view of Assets Average shows it stood at $3.0 million in 2021, then decreased by 11.84% to $2.7 million in 2022, then dropped by 4.07% to $2.6 million in 2023, then soared by 54.88% to $4.0 million in 2024, then advanced by 16.37% to $4.6 million in 2025.
• The last three Assets Average figures came in at $4.6 million (Q4 2025), $4.0 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.